Evidence map›Paper›PMID 36345041›Full record

ArticleClinical epigenetics2022

First step towards a consensus strategy for multi-locus diagnostic testing of imprinting disorders.

Deborah Mackay, Jet Bliek, Masayo Kagami, Jair Tenorio-Castano, Arrate Pereda, Frédéric Brioude, Irène Netchine, Dzhoy Papingi, Elisa de Franco, Margaret Lever and 19 more

Open access · goldAbstract read
In one paragraph

Article in Clinical epigenetics, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 25 papers.

0numbers the graph read from it
0cells of the map it votes in
25citing papers in PubMed
6.0field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

25 citing papers in PubMed, 33 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Long-term Follow-up of a Late Diagnosed Patient with Temple SyndromeJournal of clinical research in pediatric endocrinology · 2024
    Article
  12. Article
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

29 authors at 20 institutions in 8 countries.

Deborah MackayWessex Regional Genetics Laboratory, Salisbury, SP2 8BJ, UK.
Jet BliekDepartment of Human Genetics, Laboratory for Genome Diagnostics, Amsterdam UMC, Amsterdam, Netherlands.
Masayo KagamiDepartment of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan.
Jair Tenorio-CastanoInstituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Arrate PeredaRare Diseases Research Group, Molecular (Epi)Genetics Laboratory, Bioaraba Health Research Institute, Araba University Hospital-Txagorritxu, C/Jose Atxotegi s/n, 01009, Vitoria-Gasteiz, Spain.
Frédéric BrioudeINSERM, UMR 938, Centre de Recherche Saint-Antoine (CRSA), APHP Hôpital Trousseau, Sorbonne Université, 75012, Paris, France.
Irène NetchineINSERM, UMR 938, Centre de Recherche Saint-Antoine (CRSA), APHP Hôpital Trousseau, Sorbonne Université, 75012, Paris, France.
Dzhoy PapingiInstitute of Human Genetics, University of Hamburg, Hamburg, Germany.
Elisa de FrancoInstitute of Biomedical and Clinical Science, University of Exeter Medical School, Exeter, UK.
Margaret LeverWessex Regional Genetics Laboratory, Salisbury, SP2 8BJ, UK.
Julie SillibourneWessex Regional Genetics Laboratory, Salisbury, SP2 8BJ, UK.
Paola LombardiDepartment of Human Genetics, Laboratory for Genome Diagnostics, Amsterdam UMC, Amsterdam, Netherlands.
Véronique GastonCentre de Référence du Syndrome de Prader-Willi et Autres Obésités Avec Troubles du Comportement Alimentaire, Unité d'Endocrinologie, Obésité, Maladies Osseuses, Génétique et Gynécologie Médicale, Hôpital des Enfants CHU Toulouse, Toulouse, France.
Maithé TauberCentre de Référence du Syndrome de Prader-Willi et Autres Obésités Avec Troubles du Comportement Alimentaire, Unité d'Endocrinologie, Obésité, Maladies Osseuses, Génétique et Gynécologie Médicale, Hôpital des Enfants CHU Toulouse, Toulouse, France.
Gwenaelle DieneLaboratoire de Génétique Médicale, Institut Fédératif de Biologie CHU Toulouse, Toulouse, France.
Eric BiethLaboratoire de Génétique Médicale, Institut Fédératif de Biologie CHU Toulouse, Toulouse, France.
Luis FernandezInstituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Julian NevadoInstituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Zeynep TümerKennedy Center, Department of Clinical Genetics, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark.
Andrea RiccioDepartment of Environmental, Biological and Pharmaceutical Sciences and Technologies, University of Campania 'Luigi Vanvitelli', Caserta, Italy.
Eamonn R MaherDepartment of Medical Genetics, University of Cambridge, Cambridge, CB2 0QQ, UK.
Jasmin BeygoInstitute of Human Genetics, University Hospital Essen, University Duisburg-Essen, Essen, Germany.
Pierpaola TannorellaMedical Cytogenetics and Molecular Genetics Laboratory, Centro di Ricerche e Tecnologie Biomediche, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Silvia RussoMedical Cytogenetics and Molecular Genetics Laboratory, Centro di Ricerche e Tecnologie Biomediche, Istituto Auxologico Italiano, IRCCS, Milan, Italy.
Guiomar Perez de NanclaresERN-Ithaca, European Reference Networks, Brussels, Belgium.
I Karen TempleFaculty of Medicine, University of Southampton, Southampton, SO17 1BJ, UK.
Tsutomu OgataDepartment of Pediatrics, Hamamatsu Medical Center and Department of Biochemistry, Hamamatsu University School of Medicine, Hamamatsu, Japan.
Pablo LapunzinaInstituto de Genética Médica y Molecular (INGEMM)-IdiPAZ, Hospital Universitario La Paz, Madrid, Spain.
Thomas EggermannInstitute of Human Genetics, Medical Faculty, RWTH Aachen University, Pauwelsstr. 30, 52074, Aachen, Germany. teggermann@ukaachen.de.
Centre for Biomedical Network Research on Rare Diseases · ESHôpital des Enfants · FRInstituto de Salud Carlos III · ESIRCCS Istituto Auxologico Italiano · ITLaboratoire de Génétique MédicaleUniversity of Southampton · GBAmsterdam University Medical Centers · NLAssistance Publique – Hôpitaux de Paris · FRFuture Diagnostics (Netherlands) · NLHamamatsu University School of Medicine · JPHospital Txagorritxu · ESInserm · FRInstitute of Genetics and Biophysics · ITNational Center For Child Health and Development · JPRWTH Aachen University · DEUniversität Hamburg · DEUniversity Hospital Southampton NHS Foundation Trust · GBUniversity of Cambridge · GBUniversity of Copenhagen · DKUniversity of Duisburg-Essen · DE

Funding

Department of HealthWellcome TrustWellcome Trust WT098395/Z/12/Z
6 · The paper itself

Abstract

backgroundImprinting disorders, which affect growth, development, metabolism and neoplasia risk, are caused by genetic or epigenetic changes to genes that are expressed from only one parental allele. Disease may result from changes in coding sequences, copy number changes, uniparental disomy or imprinting defects. Some imprinting disorders are clinically heterogeneous, some are associated with more than one imprinted locus, and some patients have alterations affecting multiple loci. Most imprinting disorders are diagnosed by stepwise analysis of gene dosage and methylation of single loci, but some laboratories assay a panel of loci associated with different imprinting disorders. We looked into the experience of several laboratories using single-locus and/or multi-locus diagnostic testing to explore how different testing strategies affect diagnostic outcomes and whether multi-locus testing has the potential to increase the diagnostic efficiency or reveal unforeseen diagnoses.

resultsWe collected data from 11 laboratories in seven countries, involving 16,364 individuals and eight imprinting disorders. Among the 4721 individuals tested for the growth restriction disorder Silver-Russell syndrome, 731 had changes on chromosomes 7 and 11 classically associated with the disorder, but 115 had unexpected diagnoses that involved atypical molecular changes, imprinted loci on chromosomes other than 7 or 11 or multi-locus imprinting disorder. In a similar way, the molecular changes detected in Beckwith-Wiedemann syndrome and other imprinting disorders depended on the testing strategies employed by the different laboratories.

conclusionsBased on our findings, we discuss how multi-locus testing might optimise diagnosis for patients with classical and less familiar clinical imprinting disorders. Additionally, our compiled data reflect the daily life experiences of diagnostic laboratories, with a lower diagnostic yield than in clinically well-characterised cohorts, and illustrate the need for systematising clinical and molecular data.

Indexed as

Beckwith-Wiedemann SyndromeSilver-Russell SyndromeDiagnostic Techniques and ProceduresDNA MethylationGenomic ImprintingGrowth DisordersHumansGenetic testingImprinting disordersMulti-locus imprinting disorderMulti-locus testingOverlapping phenotypesUnexpected molecular diagnosis

Identifiers

PMID36345041
PMCPMC9641836
OpenAlexW4308636364

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.